MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Consolidator ... Mass Market Scale-up, Global Reach, Public Capital
1) Consolidators: Life Science & Therapeutics Sector
*Consolidators: Therapeutics Sector
*Consolidators: Diabetes and Kidney Health Companies
Bio-Rad Laboratories, Inc. [NYSE:BIO]
Finance & Acquisitions: Bio-Rad
QuantaLife
Parents
*Architects: Biotechnology _ Genomics, Genetic Testing, Gene & DNA Sequencing, NGS (Next Generation Sequencing) Companies
*Architects: Biotechnology (Laboratory Equipment, Testing, Tools, Reagents & Test Kit Companies)
*Industry: California
Companies: Acquired_(M&A)
Finance & Acquisitions: Bio-Rad
Children
2011: Bio Rad Laboratories Inc Acquires QuantaLife for or $162 Million (2011)
Develops, manufactures and markets a revolutionary nucleic acid testing concept for the Life Science Research, Clinical Molecular Diagnostics, Personalized Medical Care and Industrial markets.
Has collected $17.2 million in Series B financing (2010)
Has developed a “digital PCR” method to quantify small amounts of DNA for gene expression analysis and other applications
Pleasanton, California
Provides advanced genetic analysis systems for research. QuantaLife has commercialized the Droplet Digital™ (ddPCR) system, the most accurate genetic analysis platform available today.
The round was led by Series A investor Paladin Capital Group and was joined by new investors Merieux Developement and Vital Financial.